Join Dr. Neil Bhowmick for a live AMA on the tumor microenvironment, drug resistance, and cutting-edge cancer therapies. Ask questions and gain insights from a pioneering leader transforming cancer research and treatment.

During this interactive session, Dr. Hartung will discuss how organoids (miniature, lab-grown versions of organs) are transforming personalized medicine, drug screening and disease modeling.

In this live "Ask Me Anything" session, Dr. Lukas Lange, CEO and co-founder of Probably Genetic, will answer your questions about the transformative power of precision medicine in addressing rare genetic disorders.

Join us on March 24 for an exclusive Ask Me Anything session with Dr. Robert Osborne, Senior Vice President of R&D at biomodal, as we delve into the cutting-edge field of Epigenetic Biomarkers for Early Disease Detection.

Involved in immunotherapy research? Join our AMA Q&A with Professor Paul Moss to explore advances and applications in treating diseases. This hour-long virtual session lets you ask your questions live and dive deep into the field.

Cell-to-cell communication in cancer is pivotal for tumor progression, metastasis, and treatment resistance. This complex network of signalling pathways allows cancer cells to interact, shaping their behavior and response to therapy.